The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Antonio Sacco1, Adriano Fenotti2, Loredana Affò2, Stefano Bazzana3, Domenico Russo4, Marco Presta5, Michele Malagola4, Antonella Anastasia6, Marina Motta6, Christopher J. Patterson7, Giuseppe Rossi6, Luisa Imberti1, Steven P. Treon7, Irene M. Ghobrial7 and Aldo M. Roccaro1 1 ASST Spedali Civili, Coordinamento e Progettazione Ricerca Clinica, CREA Laboratory, Brescia, BS, Italy 2 ASST Spedali Civili, SITRA, Brescia, BS, Italy 3 ASST Spedali Civili, Collegio IPASVI, Brescia, BS, Italy 4 University of Brescia Medical School, Adult Bone Marrow Transplantation Unit, Brescia, BS, Italy 5 University of Brescia Medical School, Dept. of Molecular and Translational Medicine, Brescia, BS, Italy 6 ASST Spedali Civili, Dept. of Hematology, Brescia, BS, Italy 7 Dana-Farber Cancer Institute, Dept. Medical Oncology, Harvard Medical School, Boston, MA, USA Correspondence to: Aldo M. Roccaro, email: // <![CDATA[ mail("aldomaria.roccaro","asst-spedalicivili",26,"") // ]]> Keywords: Waldenström’s Macrolobulinemia, genomics Received : November 17, 2016 Accepted : February 20, 2017 Published: March 11, 2017